Announcement
FLLYR: RYM: Ryman full year underlying profit of $242 million, up 6.6%
08:31am
RYM
12/06/2020 08:31
FLLYR
PRICE SENSITIVE
REL: 0831 HRS Ryman Healthcare Limited
FLLYR: RYM: Ryman full year underlying profit of $242 million, up 6.6%
Ryman reports audited full year underlying profit of $242 million, up 6.6%
Highlights:
o Audited underlying profit up 6.6% to $242 million in the year to March 31,
2020
o Audited reported (IFRS) profit, including unrealised valuation gains, down
19% to $265 million, due to changes in valuation assumptions impacted by
COVID-19
o Final dividend of 12.7 cents, taking the full year dividend lifted to 24.2
cents per share, in line with growth in underlying profit
o Operating cash flows rose 12% to $449.8 million, cash receipts up 12% to
$1.13 billion
o Significant investment in keeping residents and staff safe from COVID-19
o Record $711.4 million invested in portfolio, and construction under way on
12 new villages with 841 beds and units built in the year, up 11%
o Total assets of $7.68 billion, up 15%
o Continued strong demand for villages with only 1.7% of resale units unsold
at year end, and 98% occupancy at established care centres
o New Takapuna site acquired, thirteenth site in Auckland - landbank at 6600
beds and units
o Seven new villages approved by councils; another seven new village
applications lodged
o Named Most Trusted Brand in the NZ industry for sixth time, awarded the
Dementia Friendly tick from Alzheimers NZ, staff and residents happier than
ever
o Targeting having five villages open in Victoria by December 31, 2020
Ryman Healthcare's audited full year underlying profit rose 6.6% to $242
million thanks to strong demand at new villages and the company is in good
shape to recover from the disruption caused by COVID-19.
Audited reported (IFRS) profit, which includes unrealised fair value gains on
investment property, was $265 million, down 19%. The unrealised fair value
movement was down $173 million in the year due to changes in valuation
assumptions impacted by COVID-19.
This was partially offset by the reintroduction of tax depreciation by the
New Zealand Government on commercial buildings which resulted in a deferred
tax credit of $86 million.
Shareholders will receive an increased final dividend of 12.7 cents per
share, taking the total dividend for the year to 24.2 cents per share, in
line with the increase in underlying profit. The dividend will be paid on
July 10, the record date for entitlements is June 26.
The growth in underlying profits was driven by strong development margins,
particularly from Ryman's Melbourne and Auckland villages.
Cash generation was strong during the year with operating cashflows up 12% to
$449.8 million. Total assets were $7.68 billion, up 15%, reflecting the value
created by ongoing development and strong demand. Ryman invested $711.4
million during the year with construction across 12 sites and continued
investment in innovation and its existing portfolio.
Chairman Dr David Kerr said it was a solid result given the disruption caused
by COVID-19.
"The most important thing for us was to continue to keep COVID-19 out and to
look after our 11,600 residents and 6,000 staff. We have been successful so
far, but we take nothing for granted.
"We have had huge commitment from our team, and a massive amount of goodwill
from our residents and their families throughout. I thank everyone who has
played a part in this and continues to do so during the recovery."
The COVID challenge had proven the Ryman model of retirement living and care
was more relevant to our residents and their families than ever, Dr Kerr
said.
"We took some big decisions, including starting to ban visitors from
countries with COVID-19 infections in January, locking down access to our
villages in March, increasing pay at our villages during lockdown and
stocking up on PPE to keep everyone safe. Our decisions mean we are in good
shape for the recovery.
"We are a values-based company - people come first. With this approach we
will weather the storm and enhance our reputation as a safe haven for people
in retirement and a great place to work."
Ryman was able to reassign members of its construction team to help with
security and grocery deliveries during the Level 4 lockdown and its marketing
and sales staff worked in support roles, helping with welfare calls and
communications, Dr Kerr said.
Chief Executive Gordon MacLeod said Ryman had been on track to finish the
year strongly before the profound impact of COVID-19 began to be felt.
"We had our strongest February ever with record sales and we had built a lot
of momentum for March, which is the end of the selling season for us and
traditionally our biggest month," Mr MacLeod said.
"The decisions we took to close down our villages to visitors early had an
impact on sales activity in March, and we had to shut our construction sites
at short notice."
Ryman's villages and high-quality care offering continued to be in strong
demand, with low resale stock. Care occupancy in established villages was at
98% at March 31.
"We are beginning to see sales activity ramp up, it is good to be building
again, and our sales and construction teams are up for the challenge," Mr
MacLeod said.
Ryman's balance sheet remains well placed to support the build programme, but
all development decisions would be carefully considered as the New Zealand
and Victorian economies recover from the impact of COVID-19.
Ryman has work under way on 12 sites in New Zealand and Victoria, and its
strongest ever land bank with 60% of units and beds consented.
"We have had a busy 12 months with seven new villages approved by councils,
and we have another seven new village applications lodged," Mr MacLeod said.
Ryman has purchased a new village site in Takapuna, which will become its
thirteenth village in Auckland.
Mr MacLeod confirmed that Ryman is still targeting to have its fifth village
open in Victoria by the end of the year.
During the year Ryman was voted the Most Trusted Brand in the New Zealand
industry for the sixth time and was awarded Dementia Friendly status for all
its villages by Alzheimers NZ.
Staff and residents were happier than ever, with significant lifts in survey
results during the COVID emergency.
"We are incredibly grateful to our team for the care and support they
provided for our residents over the past three months. We know our residents
think the world of them, and so do I," Mr MacLeod said.
About Ryman:
Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 36
retirement villages in New Zealand and Australia. Ryman villages are home to
11,600 residents, and the company employs more than 6,000 staff.
Contacts:
For media information or images contact David King, Corporate Affairs
Manager, on 021 499 602 (+64 21 499 602) or email
david.king@rymanhealthcare.com
For investor relations information contact Michelle Perkins, Investor
Relations Manager, on 027 222 9684 (+64 27 222 9684) or email
michelle.perkins@rymanhealthcare.com
End CA:00354544 For:RYM Type:FLLYR Time:2020-06-12 08:31:11
Click here
to view related attachments.
